GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cantech Holding Inc (OTCPK:BSSP) » Definitions » Debt-to-Revenue

Cantech Holding (Cantech Holding) Debt-to-Revenue : N/A (As of Sep. 2015)


View and export this data going back to 2011. Start your Free Trial

What is Cantech Holding Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Cantech Holding's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2015 was $0.35 Mil. Cantech Holding's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2015 was $0.03 Mil. Cantech Holding's annualized Revenue for the quarter that ended in Sep. 2015 was $0.00 Mil.

Cantech Holding Debt-to-Revenue Historical Data

The historical data trend for Cantech Holding's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantech Holding Debt-to-Revenue Chart

Cantech Holding Annual Data
Trend Dec11 Dec12 Dec13 Dec14
Debt-to-Revenue
N/A 1.67 N/A N/A

Cantech Holding Quarterly Data
Sep10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

Competitive Comparison of Cantech Holding's Debt-to-Revenue

For the Biotechnology subindustry, Cantech Holding's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cantech Holding's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cantech Holding's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cantech Holding's Debt-to-Revenue falls into.


Cantech Holding Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Cantech Holding's Debt-to-Revenue for the fiscal year that ended in Dec. 2014 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.249 + 0.001) / N/A
=N/A

Cantech Holding's annualized Debt-to-Revenue for the quarter that ended in Sep. 2015 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.351 + 0.026) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2015) Revenue data.

Cantech Holding Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cantech Holding's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cantech Holding (Cantech Holding) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cantech Holding Inc (OTCPK:BSSP) » Definitions » Debt-to-Revenue
Comparable Companies
HSTC NTRR TLOG NSPX ERGO OPLI GLAG FPMI ADYNF ENTB CAPS BTHE GOVX LCAR ARNI IMUC CTBO GNBT ICOTF TIKRF
Traded in Other Exchanges
N/A
Address
120 W Pomona Avenue, Monrovia, CA, USA, 91016
Website
http://www.cantechholding.com
Cantech Holding Inc is a development stage immunotherapeutic-based technology company. Principally, it is focused on commercialization of its proprietary proteins for the treatment of cancer and various infectious diseases. Its Irreversible Pepsine Fraction (IPF) is a therapeutic platform technology that can be used to facilitate varieties of applications. The company's product consists of IMMUNE-THERAPEUTIC PROTEIN which is a therapeutic protein isolated from porsine pepsin and is irreversible, modified, and fractionated to the sequence IPF.
Executives
Pamela Elliott officer: Secretary and Treasurer 1960 GRAEAGLE LANE, LINCOLN CA 95648